S&P 500 Industrials Sector SEC Filings — April 09, 2026

09-04-2026

SBA Communications Corporation's definitive proxy statement for the 2026 Annual Meeting of Shareholders on May 22, 2026, at 10:00 AM ET in Boca Raton, Florida, seeks shareholder approval for electing directors Steven E. Bernstein, Laurie Bowen, and Amy E. Wilson for three-year terms; an advisory vote on named executive officer compensation; and ratification of Ernst & Young LLP as independent auditors for fiscal 2026. The Board recommends voting FOR all proposals, with disclosures on corporate governance, executive compensation for PEOs Jeffrey A. Stoops and Brendan T. Cavanagh from 2021-2025, and company operations in wireless infrastructure across multiple countries. No financial performance metrics or period-over-period comparisons are detailed in the provided filing excerpt.

• ·Record Date: March 26, 2026
• ·Meeting Location: 8051 Congress Avenue, Boca Raton, Florida 33487
• ·Voting eligibility: Shareholders of record at close of business on March 26, 2026
• ·Principal operations: United States, Brazil, Chile, Costa Rica, Ecuador, El Salvador, Guatemala, Honduras, Nicaragua, Panama, Peru, South Africa, Tanzania

09-04-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed a Form 8-K on April 9, 2026, under Items 8.01 and 9.01, announcing the issuance of a press release titled 'AITX's RAD-R Unveils New radcam.ai Built Around the RADCam Experience,' attached as Exhibit 99.1. The information is furnished and not deemed filed for liability purposes. No financial metrics or period comparisons are reported.

• ·Filing is not intended to satisfy other filing obligations under Rule 425, 14a-12, 14d-2(b), or 13e-4(c).
• ·Registrant is incorporated in Nevada with CIK 0001498148 and EIN 27-2343603.
• ·Principal executive offices at 10800 Galaxie Avenue, Ferndale, Michigan 48220.

09-04-2026

Einride AB filed a Rule 425 under the Securities Act of 1933 (deemed filed under Rule 14a-12 of the Exchange Act) on April 9, 2026, disclosing an investor presentation made available on April 8, 2026, regarding a proposed business combination with Legato Merger Corp. III (Commission File No. 001-41945). The presentation is strictly for informational purposes, not constituting an offer, solicitation, or recommendation, and is laden with extensive disclaimers on forward-looking statements, risks, and lack of warranties. No financial metrics, transaction terms, or performance data are included.

• ·Subject Company: Legato Merger Corp. III, Commission File No.: 001-41945
• ·References Legato's prospectus dated February 5, 2024, filed with SEC on February 6, 2024

09-04-2026

On April 8, 2026, IDEAYA Biosciences, Inc. entered into a clinical collaboration agreement with AstraZeneca plc to evaluate IDE849, a potential first-in-class DLL3 TOP1 antibody-drug conjugate, in combination with AstraZeneca's Imfinzi (durvalumab) for extensive-stage small cell lung cancer (SCLC). IDEAYA will sponsor the clinical combination study, with AstraZeneca supplying Imfinzi, as part of advancing a multi-site global Phase 1 trial for IDE849 in DLL3 upregulated solid tumors including SCLC, neuroendocrine carcinomas (NECs), neuroendocrine tumors (NETs), and melanoma.

• ·Trial enrollment in North America, Europe, Australia, South America, and Asia.
• ·DLL3 upregulated in SCLC, NECs, NETs, non-small cell lung cancer, and melanoma.
• ·DLL3 has limited extracellular expression in normal tissues.

09-04-2026

The Gabelli Dividend & Income Trust (GDV-PK) has released definitive additional proxy materials (DEFA14A) urging shareholders to vote for its three Board-nominated trustees using the WHITE proxy card at the Annual Meeting on May 11, 2026, and explicitly not to support activist investor Saba Capital Management's nominee via the GOLD proxy card. The Board states it evaluated Saba’s nominee in good faith but concluded the individual lacks comparable experience in Fund strategy, service providers, and U.S. investment company governance, potentially prioritizing Saba’s short-term objectives over long-term shareholder interests. No financial metrics are provided, but the proxy contest highlights ongoing governance tensions with no resolution indicated.

• ·Annual Meeting of Shareholders: May 11, 2026
• ·Shareholder hotline: 1-888-548-6498 (Mon-Fri, 9:00am-10:00pm Eastern Time)
• ·Proxy cards: WHITE (Board-supported), GOLD (Saba-supported, urged not to use)
• ·If GOLD card returned previously, WHITE card can revoke it

09-04-2026

Janus Henderson Group plc filed additional definitive proxy materials (DEFA14A) on April 9, 2026, supplementing the proxy statement originally filed on March 11, 2026 (mailed March 12), and further supplemented on March 27 and April 7, 2026, in connection with a proposed transaction. A related Schedule 13E-3 transaction statement was filed on March 11, 2026, and amended as recently as March 30, 2026. Shareholders are urged to review these and any future SEC filings for important information, available free on the SEC website or Janus Henderson's investor relations page.

• ·References financials for year ended December 31, 2025, in other filings.
• ·Documents available at https://www.sec.gov and https://ir.janushenderson.com

09-04-2026

New Providence Acquisition Corp. III filed a Form 425 disclosing a Yahoo Finance TV interview with Abra Financial Holdings, Inc. CEO Bill Barhydt on April 8, 2026, discussing the $750 million SPAC business combination announced March 16, 2026, to list Abra on NASDAQ under ticker ABRX. Barhydt expressed optimism on Bitcoin's potential to hit all-time highs amid rising global liquidity, while highlighting Abra's DeFi lending advantages over private credit, noting past counterparty risks in centralized lending have been mitigated. The filing includes standard forward-looking statement disclaimers and risks related to the merger completion.

• ·Business Combination Agreement dated March 16, 2026, between Abra Financial Holdings, Inc., New Providence Acquisition Corp. III, and Aether Merger Sub I, Corp.
• ·Upcoming Registration Statement on Form S-4 with definitive proxy statement/prospectus.
• ·Post-merger ticker: ABRX on NASDAQ.
• ·Abra operates as a registered investment advisor (RIA).

09-04-2026

Wabash National Corporation announced the transition of Michael N. Pettit from Senior Vice President, Chief Growth Officer to a non-executive Senior Advisor role effective April 8, 2026, with his employment continuing until the third quarter of 2026 to ensure a smooth handover. During this transition period, Pettit will receive continued annual base salary at $575,000, pro-rated 2026 incentive bonus eligibility, and vesting of existing equity awards, but no new grants. Upon separation, he will be eligible for severance under the Executive Severance Plan, subject to release of claims and covenant compliance.

• ·Transition Date: April 8, 2026
• ·Separation Date: Third quarter of 2026
• ·Pettit reports to Chief Executive Officer or designee as Senior Advisor
• ·No participation in Change in Control Plan post-Transition Date

09-04-2026

LPWM LLC filed its 13F-HR on April 9, 2026, for the quarter ended March 31, 2026, reporting 94 equity holdings with a total market value of $396337243. The portfolio is diversified across individual stocks like Alphabet (Class A: $1116857, Class C: $833190), Amazon ($1648117), Apple ($935463), NVIDIA ($4010572), and Microsoft ($668573), alongside substantial ETF positions in iShares and Vanguard funds. All positions are held with sole voting and dispositive power.

• ·Filing covers period ended 03-31-2026 with report date 04-08-2026.
• ·LPWM LLC located at 121 S 8th Street Suite 1110, Minneapolis, MN 55402.
• ·Largest ETF holding values include iShares Tr Rus Mdcp Val ETF at $33037978 and iShares Tr S&P 500 Val ETF at $70080747.

09-04-2026

Neogen reported fiscal third quarter 2026 revenue of $211.2 million, down 4.4% YoY from $221.0 million, driven by a 20.1% decline in Animal Safety revenue to $54.5 million due to third-party supplier challenges, while Food Safety revenue grew 2.6% to $156.7 million with core growth of 4.0%. The company recorded a net loss of $17.0 million (GAAP EPS $(0.08)) but delivered Adjusted EBITDA of $48.2 million (22.8% margin, up from 22.0% YoY) and raised FY2026 revenue guidance to $857-860 million. Additionally, Neogen announced the divestiture of its Genomics business to Zoetis for $160.0 million (net proceeds ~$140.0 million), expected to close in 2Q FY27.

• ·Indicator Testing & Culture Media up 11.0% YoY to $83.0M in Food Safety Q3 FY2026.
• ·Biosecurity Products in Food Safety down 66.9% YoY to $3.9M in Q3 FY2026.
• ·Domestic revenue down 11.4% YoY to $102.3M; International up 3.1% to $108.9M in Q3 FY2026.
• ·Petrifilm® manufacturing transition on track for November FY27.
• ·FY2026 guidance: Revenue $857-860M (raised from $845-855M), Adjusted EBITDA ~$175M.

09-04-2026

Selby Wealth Management, LLC disclosed total holdings valued at $253,872,916 across 81 positions in its 13F-HR filing as of March 31, 2026. The portfolio features significant ETF allocations including J.P. Morgan Core Plus BD ETF ($18,544,977), Fidelity Total Bond ETF ($17,319,692), and BlackRock iShares Flexible ETF ($12,704,093), alongside stocks like Apple Inc. ($3,939,342). No period-over-period changes or performance metrics are provided in the filing.

• ·All holdings reported as sole discretionary with no shared or other voting authority.
• ·Business address: 2200 Powell Street, Suite 350, Emeryville, CA 94608.
• ·Filer CIK: 0002110725; SEC file number: 028-26303.

09-04-2026

LifeGuide Financial Advisors, LLC disclosed total holdings of $312,728,791 across 46 positions, all held on a sole discretionary basis, as of March 31, 2026. Largest positions include Dimensional ETF Trust Global Real Estate ETF ($66,705,702), Schwab Strategic Trust US TIPS ETF ($51,664,331), and Dimensional ETF Trust US Core Equity 2 ($29,387,908). The filing was submitted on April 9, 2026, and signed by David Lutz, Chief Compliance Officer.

• ·All 46 positions held as sole discretionary with no shared or other manager discretion.
• ·Address: 400 W. Main St., Mechanicsburg, PA 17055.
• ·Filing covers period ending March 31, 2026.

09-04-2026

PTM Wealth Management, LLC filed its 13F-HR on April 9, 2026, disclosing $188701108 in total portfolio value across 56 holdings as of March 31, 2026. The portfolio consists entirely of sole discretionary positions in equities and ETFs, with no other managers or voting restrictions noted. Largest holdings include Schwab Strategic Tr Fundamental US L at 29579428 USD (1051900 shares), Innovator Etfs Trust Defined Wlt Shld at 26424961 USD (787160 shares), and SSGA Active ETF Tr State Street Ult at 19044752 USD (471521 shares).

• ·All 56 positions held with sole investment discretion.
• ·No put or call options reported.
• ·Filing covers period ending 03-31-2026.

09-04-2026

Mereo BioPharma Group plc has issued its DEF 14A proxy statement for the 2026 Annual General Meeting on May 14, 2026, at 2:00 p.m. BST (9:00 a.m. ET) in London, seeking shareholder approval for 11 resolutions including adoption of the 2025 annual accounts, re-appointment of PricewaterhouseCoopers LLP as auditors, approval of directors' remuneration report and policy, advisory approval of named executive officer compensation, re-election of directors Justin Roberts, Dr. Daniel Shames, and Marc Yoskowitz, and renewal of authorities to allot shares up to a maximum aggregate nominal amount of £3,591,354.73 expiring June 30, 2029. The Board unanimously recommends voting FOR all resolutions. No financial performance data or period-over-period comparisons are provided in the filing.

• ·Proxy appointment deadline for ordinary shares: 2:00 p.m. BST (9:00 a.m. ET) on May 12, 2026.
• ·ADS proxy cards deadline: 10:00 a.m. ET (3:00 p.m. BST) on May 8, 2026.
• ·Record date for ordinary shares: 6:00 p.m. BST (1:00 p.m. ET) on May 12, 2026.
• ·ADS Record Date: 5:00 p.m. ET on April 9, 2026.
• ·Share allotment authority replaces prior authority from May 22, 2023 AGM.

09-04-2026

PHINIA INC. issued a DEFA14A proxy notice card for its upcoming shareholder meeting related to the fiscal year ended December 31, 2025, outlining three proposals: election of eight director nominees, advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent registered public accounting firm. The board recommends voting 'For' all items. Shareholders can vote online at www.ProxyVote.com or request free paper/email copies of materials by May 8, 2026.

• ·Shareholder meeting materials available online at www.ProxyVote.com or by calling 1-800-579-1639 or emailing sendmaterial@proxyvote.com (include control number).
• ·Requests for paper/email copies must be made prior to May 8, 2026.
• ·This is not a votable ballot; follow instructions on reverse side to vote.

09-04-2026

Laureate Education, Inc. filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting of Stockholders on May 21, 2026, held virtually. Key proposals include electing nine directors, an advisory vote to approve named executive officer compensation, ratification of PricewaterhouseCoopers LLP as independent auditors for the year ending December 31, 2026, and approval of the 2026 Long-Term Incentive Plan. The board recommends voting 'For' all items.

• ·Annual Meeting: May 21, 2026 at 10:00 AM EDT, virtually at www.virtualshareholdermeeting.com/LAUR2026
• ·Proxy materials request deadline: May 7, 2026 via www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com
• ·Auditor appointment for fiscal year ending December 31, 2026

09-04-2026

ConnectOne Bancorp, Inc. filed a Form 8-K on April 09, 2026, under Items 8.01 and 9.01, announcing the issuance of a press release dated April 09, 2026, incorporated as Exhibit 99.1. The filing discloses securities registered pursuant to Section 12(b): Common Stock (CNOB) and Depositary Shares (CNOBP), both on NASDAQ. It is signed by William S. Burns, Senior Executive Vice President and Chief Financial Officer.

09-04-2026

The Federal Home Loan Bank of San Francisco reported the creation of direct financial obligations via two consolidated obligation bonds for which it is the primary obligor, each with a par value of $10,000,000, issued on trade dates April 6 and April 7, 2026, settling April 9, 2026, and maturing April 9, 2031. The bonds feature fixed rates of 4.250% (European callable style, next call April 9, 2027) and 4.500% (Bermudan callable style, next call October 9, 2026), as part of routine capital markets funding backed jointly by the eleven Federal Home Loan Banks. No period-over-period comparisons or performance metrics were provided, reflecting standard debt issuance activity.

• ·First bond (CUSIP 3130BAAC): Next Pay Date October 9, 2026; Rate Type Fixed Constant
• ·Second bond (CUSIP 3130BA7F): Next Pay Date October 9, 2026; Rate Type Fixed Constant
• ·Consolidated obligations are joint and several obligations of the eleven Federal Home Loan Banks, not guaranteed by the U.S. government
• ·Schedule A excludes discount notes with maturity of one year or less issued in ordinary course

09-04-2026

Overbrook Management Corp filed its 13F-HR on April 9, 2026, disclosing holdings in 51 securities as of March 31, 2026, with no prior period comparison provided in the filing. Top positions include NVIDIA Corporation at $55,637,088 (319,020 shares), Alphabet Inc Cap Stk Cl C at $37,739,588 (131,561 shares), Broadcom Inc at $34,991,963 (113,056 shares), Microsoft Corp at $29,998,207 (81,039 shares), and Amazon.com Inc at $29,927,566 (143,696 shares). Other notable holdings feature Apple Inc ($25,954,228), Eli Lilly & Co ($25,649,626), and Meta Platforms Inc Cl A ($27,037,719).

• ·Filing period end date: March 31, 2026
• ·Business address: 280 Park Avenue Suite 2402 West, New York, NY 10017
• ·Phone: 646-315-9714
• ·All holdings reported as sole voting authority (SH SOLE)

09-04-2026

Tealwood Asset Management Inc filed its 13F-HR report for the quarter ended March 31, 2026, disclosing holdings in 118 securities with a total value of $219782 thousand (219.782 million USD). The portfolio features sole voting authority across positions, with top holdings including US Bancorp (value 2915 thousand USD, 56048 shares), Advanced Micro Devices Inc (2372 thousand USD, 11660 shares), and Berkshire Hathaway Inc Del Cl B New (2168 thousand USD, 4525 shares). No prior period comparisons are provided in the filing.

• ·Filed as of date: April 09, 2026
• ·Conformed period of report: March 31, 2026
• ·Business address: 120 South 6th Street Suite 1900, Minneapolis, MN 55402
• ·SEC file number: 028-10065
• ·All positions reported with sole voting authority

09-04-2026

First Northwest Bancorp has issued a preliminary proxy statement for its 2026 Annual Meeting of Shareholders on May 19, 2026, at 4:00 p.m. PT in Port Angeles, Washington, with record date March 20, 2026. Shareholders will vote on electing nine directors, approving Second Amended and Restated Articles of Incorporation to remove supermajority voting and allow director removal with or without cause, amending the 2020 Equity Incentive Plan, an advisory vote on named executive officer compensation, and ratifying Baker Tilly US, LLP as auditor for the year ending December 31, 2026. No financial performance metrics or period-over-period comparisons are disclosed in the filing.

• ·Meeting location: Field Arts and Events Hall, 201 W. Front Street, Port Angeles, Washington 98362.
• ·ESOP voting details: sole voting power over 608,855 shares, shared voting power over 299,927 shares, shared dispositive power over 908,782 shares as of September 30, 2024.
• ·Beneficial ownership includes shares held by spouses, family, trusts, ESOP, and 401(k) Plan.

09-04-2026

Goelzer Investment Management, Inc. filed its 13F-HR report on April 9, 2026, disclosing institutional holdings as of March 31, 2026, across 297 securities with a total market value of $2,067,639,500. Top holdings by reported value include ELI LILLY & CO COM at $497,059,392 (540,417 shares), APPLE INC COM at $41,103,178 (161,957 shares), and ALPHABET INC CAP STK CL C at $25,974,687 (90,548 shares). The portfolio features broad exposure to large-cap U.S. equities, ETFs, and select international names, primarily under sole investment discretion.

• ·Report filed under SEC file number 028-14976
• ·Central Index Key (CIK): 0001550057
• ·Business address: 10 East Main Street, Suite 110, Carmel, IN 46032
• ·Predominantly sole investment discretion and voting authority across holdings

09-04-2026

Nuvera Communications, Inc. issued a DEF 14A proxy statement for its virtual Annual Meeting of Shareholders on May 21, 2026, at 10:00 a.m. CDT, seeking approval for the election of two director nominees (James J. Seifert and Colleen R. Skillings), ratification of Olsen Thielen & Co., Ltd. as independent auditor for the year ended December 31, 2026, and consideration of a non-binding shareholder proposal (Proposal 3) on which the Board makes no recommendation. As of the March 26, 2026 record date, there were 5,215,348 shares of common stock outstanding, with a quorum requiring 35% presence. The Board recommends voting FOR the nominees and auditor ratification.

• ·Quorum requires presence of 35% of outstanding shares.
• ·Proxy voting deadline: May 20, 2026, at 10:59 p.m. CDT via internet or telephone.
• ·Shareholder proposals for 2027 proxy statement due by December 11, 2026.
• ·Virtual meeting access: www.virtualshareholdermeeting.com/NUVR2026 using 16-digit control number.
• ·Board consists of eight directors serving three-year terms.

09-04-2026

The Federal Home Loan Bank of Cincinnati filed an 8-K under Item 2.03 disclosing the creation of a direct financial obligation through the commitment to issue a Consolidated Bond with a par value of $25,000,000. The bond, traded on April 6, 2026, has a fixed constant rate of 4.400%, matures on April 17, 2029, and features Optional Principal Redemption (Bermudan style) with the next call date on July 17, 2026. No other comparative financial metrics or performance changes were reported.

• ·Trade Date: April 6, 2026
• ·Settlement Date: April 17, 2026
• ·Next Pay Date: October 17, 2026
• ·CUSIP: 3130BAB2
• ·Schedule A excludes Consolidated Discount Notes due to short-term maturities (max 360 days) and does not reflect derivatives, total outstanding obligations, or GAAP adjustments

09-04-2026

Beam Global's 10-K for the year ended December 31, 2025, shows net cash used in operating activities worsening to $(10,482) from $(2,193) in 2024, reflecting increased cash burn amid persistent losses and material weaknesses in internal controls. Net cash used in investing activities improved to $(482) from $(4,054), while financing activities provided $7,467 versus $1,203. The company is addressing control deficiencies through remediation efforts, including NetSuite ERP implementation, but highlights significant risks including liquidity challenges, competition, and international expansion hurdles.

• ·Material weaknesses include ineffective ITGCs, insufficient inventory accounting controls, inadequate account reconciliations, segregation of duties issues, and oversight of international operations.
• ·Remediation efforts: enhancing ITGCs, implementing NetSuite ERP, formalizing reconciliation reviews, improving segregation of duties, and training personnel.
• ·Risks include volatility in stock price, quarterly fluctuations, failure to earn profits, inadequate capital, demand reductions, litigation, raw material cost changes, currency fluctuations, and limited public float.

09-04-2026

NIQ Global Intelligence plc has issued a proxy statement for its 2026 Annual General Meeting (AGM) on May 21, 2026, at Arthur Cox LLP offices in Dublin, Ireland, seeking shareholder approval on electing four Class I directors for terms until 2029, ratifying Ernst & Young LLP as independent auditor for the fiscal year ending December 31, 2026, advisory votes on named executive officer compensation and frequency (1, 2, or 3 years), authorizing market purchases of ordinary shares, setting price range for re-allotting treasury shares, and approving capital reduction to create distributable reserves. The record date for voting eligibility is March 27, 2026, with no financial performance metrics or period-over-period comparisons disclosed in the filing. All proposals are routine governance matters with no reported controversies or declines.

• ·Voting requirements: Proposal 1 (directors) by plurality; Proposals 2, 3, 5 by simple majority; Proposals 6, 7 by 75% majority.
• ·Irish statutory financial statements for year ended December 31, 2025 available by April 29, 2026 on investor relations website.
• ·Proxy materials available at www.ProxyVote.com; paper requests due by May 7, 2026.

09-04-2026

Photronics, Inc. held its annual shareholder meeting on April 8, 2026, where shareholders elected eight directors to the Board of Directors, ratified the appointment of Deloitte & Touche LLP as independent auditors for the fiscal year ending October 31, 2026, and approved a non-binding advisory vote on executive compensation. All three proposals passed with majority support, though some director elections saw notable withheld votes (e.g., over 5 million for Daniel Liao and Constantine S. Macricostas). Voting turnout included consistent broker non-votes of 4,782,351 across proposals.

• ·Proposal 1 votes - Michelle Almeida: 40,814,195 For, 66,498 Withheld
• ·Proposal 1 votes - David A. Garcia: 40,419,518 For, 461,175 Withheld
• ·Proposal 1 votes - Dr. Frank Lee: 39,986,306 For, 894,387 Withheld
• ·Proposal 1 votes - Adam Lewis: 39,302,318 For, 1,578,375 Withheld
• ·Proposal 1 votes - Daniel Liao: 35,474,107 For, 5,406,586 Withheld
• ·Proposal 1 votes - Constantine S. Macricostas: 35,643,875 For, 5,236,818 Withheld
• ·Proposal 1 votes - George C. Macricostas: 40,069,347 For, 811,346 Withheld
• ·Proposal 1 votes - Mitchell G. Tyson: 40,460,795 For, 419,898 Withheld
• ·Proposal 2 (Auditor Ratification): 44,791,040 For, 847,897 Against, 24,102 Abstentions
• ·Proposal 3 (Say-on-Pay): 38,999,556 For, 1,790,769 Against, 90,363 Abstentions

09-04-2026

PCB Bancorp's DEF 14A proxy statement, filed April 9, 2026, solicits votes for its 2026 Annual Meeting on May 27, 2026, including the election of eight directors (receiving the most votes), an advisory vote on named executive officer compensation, and ratification of the independent public accounting firm. As of the record date March 31, 2026, there were 14,231,423 shares of common stock outstanding, with a majority required for quorum. The Board recommends voting FOR all proposals; no financial performance metrics or period-over-period comparisons are detailed in the provided content.

• ·Annual Meeting location: 3701 Wilshire Boulevard, Suite 900, Los Angeles, California, at 11:00 a.m. Pacific Time.
• ·Voting: Directors elected by plurality; other proposals by majority of votes cast (quorum is majority of shares present).
• ·Proxy materials available online since April 9, 2026; references 2025 Annual Report on Form 10-K.

09-04-2026

Sunshine Biopharma reported fiscal 2025 revenue of $36.31 million, a modest 4.1% increase over 2024's $34.87 million, with gross profit rising 15% to $12.26 million. However, net loss widened to $5.98 million from $5.13 million, driven by higher general and administrative expenses of $18.48 million (up 12%) primarily due to a $1.75 million non-cash impairment charge. The company launched nine new generic drugs and raised $2.46 million in a registered direct offering.

• ·January 2026 cost-reduction initiatives expected to lower G&A expenses by $2 million to $3 million in 2026.
• ·Annual Report on Form 10-K for fiscal year ended December 31, 2025 filed.

09-04-2026

Definitive Healthcare Corp. terminated its Nominating Agreement with SE VII DHC AIV, L.P. ("Spectrum"), dated September 17, 2021, which had granted Spectrum the right to designate one board member while holding at least 5% of outstanding common stock. The termination followed the resignation of Spectrum's designee, Jeff Haywood, from the board on March 30, 2026, with the termination agreement executed on April 3, 2026. No financial impacts or other changes were disclosed in the filing dated April 9, 2026.

• ·Nominating Agreement granted Spectrum the right to designate one director for inclusion in the slate of nominees recommended to stockholders.
• ·Termination is permanent and irrevocable in its entirety.

09-04-2026

The Trade Desk, Inc. (TTD) filed its DEF 14A Proxy Statement for the 2026 Annual Meeting of Stockholders, scheduled virtually on May 4, 2026, at 1:00 p.m. Pacific Time. Stockholders will vote on the election of two Class I directors, a non-binding advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP (PwC) as independent auditor for the fiscal year ending December 31, 2026. The record date is April 6, 2026, with 426,989,140 shares of Class A common stock (1 vote each) and 43,108,629 shares of Class B common stock (10 votes each) outstanding.

• ·Annual Meeting participation requires 16-digit control number from proxy card.
• ·Voting deadline: 11:59 p.m. Eastern Time on May 3, 2026 via Internet or telephone.
• ·Proxy materials first mailed on or about April 15, 2026, and available at www.thetradedesk.com under 'Investors' since April 9, 2026.

09-04-2026

American Public Education, Inc. (APEI) filed a DEFA14A Definitive Additional Proxy Soliciting Materials on April 09, 2026, as part of Schedule 14A under the Securities Exchange Act of 1934. The filing was made by the registrant with no fee required. No specific proposals, financial data, or additional details are included in the provided filing excerpt.

• ·Filing Type: DEFA14A (Definitive Additional Materials)
• ·Subcategory: Proxy Statement

09-04-2026

enGene Holdings Inc. (ENGNW) filed an 8-K on April 9, 2026, disclosing amendments to its articles via a Notice of Alteration with the British Columbia Registrar of Companies, changing the company name from ENGENE HOLDINGS INC. to ENGENE THERAPEUTICS INC., effective April 8, 2026 at 12:01 AM Pacific Time. The updated Notice of Articles confirms the registered and records office at 1133 Melville Street, Suite 3500, Vancouver, BC, and lists an authorized share structure of no maximum common shares and no maximum preferred shares, both without par value. Nine directors are named, with no changes indicated in board composition.

• ·Incorporation Number: C1447134
• ·Company continued into British Columbia on October 31, 2023
• ·Notice of Alteration filed April 6, 2026 at 03:13 PM Pacific Time

09-04-2026

Avery Dennison Corporation (AVY) filed a DEFA14A Definitive Additional Materials proxy statement with the SEC on April 09, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing requires no fee and is categorized as soliciting material under §240.14a-12. No substantive details on proxy matters, votes, or financials are provided in the document header.

09-04-2026

NSTS Bancorp, Inc. announced the passing of Nathan E. Walker, Chief Executive Officer and President of North Shore Trust and Savings and Executive Vice President of the Company, who had served in those roles since 2022 after starting as a teller in 1996. Stephen G. Lear, current Chairman, President, and CEO of the Company since 2012, has been appointed CEO and President of the Bank, a role he previously held from 1997 to 2022. As of December 31, 2025, North Shore Trust and Savings reported total assets of $266.6 million.

• ·North Shore Trust and Savings has operated for over 100 years serving local communities in Waukegan and Lindenhurst, Illinois.
• ·Mr. Walker began his career at the Bank as a teller in 1996.
• ·Mr. Lear has served as a director since 2003 and Chairman of both the Company and Bank since 2012.

09-04-2026

Waters Corporation has released definitive additional proxy materials for its virtual Annual Meeting of Shareholders on May 21, 2026, at 9:00 AM ET, for shareholders of record as of March 24, 2026. Key proposals include electing 11 directors (including Dr. Flemming Ornskov, Udit Batra, and others), ratifying PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending December 31, 2026, and an advisory vote to approve executive officer compensation, with the Board recommending a FOR vote on Proposals 1, 2, and 3. No financial performance metrics or changes are detailed in these materials.

• ·Record date for shareholders: March 24, 2026
• ·Paper or email proxy materials request deadline: May 11, 2026
• ·Virtual meeting access: www.proxydocs.com/WAT (pre-registration required)
• ·Proposal 4: Any other matters properly brought before the meeting

09-04-2026

GCL Global Holdings Ltd reported FY2025 revenues of $142,072,586, up 45.7% YoY from $97,534,701, fueled by console game, hardware, and accessories (+35.4%) and game publishing (+434.2%), while media advertising services declined 17.6%. Gross profit increased 59.5% to $21,243,361 with overall margin at 15.0% (up from 13.7%), though console segment margin dropped 27.8% and selling/marketing expenses fell slightly by 1.3%; the company achieved operating income of $3,236,212 (from prior loss) and net income of $5,049,421 (from $1,960,956 loss). However, operating cash flow was negative at $(10,308,634) versus positive $1,316,296 prior year, and G&A expenses rose 17.8%.

• ·FY2025 game publishing revenues: $23,757,232 (16.7% of total)
• ·FY2025 console segment gross profit: $7,379,075 (margin down to implied lower from prior)
• ·FY2024 vs FY2023 game publishing revenues declined 43.1% to $4,446,872
• ·Net cash increase FY2025: $17,044,978 (from $502,131 in FY2024)
• ·FY2025 income tax expense: $1,128,672 (up 2017.9% YoY)

09-04-2026

Better Home & Finance Holding Co reported preliminary Q1 2026 Funded Loan Volume of $1.64B, reflecting an 89% year-over-year increase and exceeding the high end of prior guidance ($1.40B to $1.55B). Following the anticipated offering close, the company expects approximately $130M in cash and cash equivalents, including $24M from its U.K.-based bank. The company reaffirmed its target of $1.0B in monthly loan volume (funded and processed) by the end of May 2026, driven by Tinman® AI Platform partnership growth.

• ·Filing date: April 09, 2026
• ·SEC Items reported: 2.02 (Results of Operations), 8.01 (Other Events), 9.01 (Financial Statements)
• ·Subcategory: Unregistered Securities Sale

09-04-2026

Biodesix, Inc. (BDSX) has issued its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders, to be held virtually on May 19, 2026, at 1:00 p.m. Mountain Time, soliciting votes on electing two Class III directors (to serve until 2029), a non-binding advisory approval of named executive officer compensation, a non-binding advisory vote on say-on-pay frequency (board recommends every one year), and ratification of KPMG LLP as independent auditors for the year ending December 31, 2026. As of the record date of March 23, 2026, there were 10,107,219 shares of common stock issued and outstanding. The board recommends voting 'For' all proposals, with proxy materials provided via 'notice and access' model starting April 9, 2026.

• ·Virtual meeting access: www.proxydocs.com/BDSX (registration required with control number)
• ·Voting deadline for internet/telephone/mail: 11:59 p.m. ET on May 18, 2026
• ·Proxy materials and 2025 Form 10-K available at https://investors.biodesix.com/investor-relations and www.proxydocs.com/BDSX

09-04-2026

ANI Pharmaceuticals, Inc. (ANIP) filed a DEFA14A Definitive Additional Materials proxy statement on April 09, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee was required and is classified as soliciting material under §240.14a-12. No specific financial data, proposals, or other details are provided in the filing header.

• ·Filing classified as Definitive Additional Materials, not Preliminary or Confidential.